ClinVar Miner

Submissions for variant NM_022455.4(NSD1):c.6349C>T (p.Arg2117Ter) (rs587784190)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000342078 SCV000329442 pathogenic not provided 2017-02-21 criteria provided, single submitter clinical testing The R2117X nonsense mutation in the NSD1 gene has been reported previously in association with Sotos syndrome (Tong et al., 2005). This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay.
Genetic Services Laboratory, University of Chicago RCV000146920 SCV000194249 pathogenic Sotos syndrome 1 2013-02-08 criteria provided, single submitter clinical testing
Invitae RCV000468338 SCV000546557 pathogenic Beckwith-Wiedemann syndrome 2016-08-25 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal at codon 2117 (p.Arg2117*) of the NSD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12807965, 15942875, 17565729). This particular variant has been reported in the literature as a de novo finding in an individual with Sotos syndrome (PMID: 16232326). ClinVar contains an entry for this variant (Variation ID: 159412). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.